Centaurus Financial Inc. grew its stake in shares of American Tower Co. (NYSE:AMT – Free Report) by 14.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,215 shares of the real estate investment trust’s stock after purchasing an additional 156 shares during the quarter. Centaurus Financial Inc.’s holdings in American Tower were worth $282,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in AMT. Cultivar Capital Inc. bought a new position in shares of American Tower during the second quarter valued at approximately $25,000. Fortitude Family Office LLC grew its holdings in American Tower by 269.0% in the 3rd quarter. Fortitude Family Office LLC now owns 107 shares of the real estate investment trust’s stock worth $25,000 after buying an additional 78 shares in the last quarter. Fairscale Capital LLC bought a new position in American Tower in the 2nd quarter worth approximately $27,000. Hobbs Group Advisors LLC bought a new position in American Tower in the 2nd quarter worth approximately $29,000. Finally, Northwest Investment Counselors LLC bought a new position in American Tower in the 3rd quarter worth approximately $30,000. 92.69% of the stock is owned by institutional investors.
American Tower Price Performance
Shares of NYSE:AMT opened at $209.31 on Thursday. American Tower Co. has a one year low of $170.46 and a one year high of $243.56. The stock has a fifty day moving average of $216.94 and a 200-day moving average of $212.14. The company has a market capitalization of $97.81 billion, a PE ratio of 88.32, a price-to-earnings-growth ratio of 1.38 and a beta of 0.84. The company has a debt-to-equity ratio of 3.27, a quick ratio of 0.69 and a current ratio of 0.69.
American Tower Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Wednesday, October 9th were paid a dividend of $1.62 per share. This represents a $6.48 annualized dividend and a yield of 3.10%. The ex-dividend date was Wednesday, October 9th. American Tower’s dividend payout ratio (DPR) is currently 273.42%.
Analyst Ratings Changes
A number of equities analysts recently issued reports on AMT shares. Mizuho increased their price objective on American Tower from $205.00 to $221.00 and gave the stock a “neutral” rating in a report on Thursday, September 12th. Royal Bank of Canada increased their price objective on American Tower from $225.00 to $236.00 and gave the stock an “outperform” rating in a report on Thursday, August 15th. BMO Capital Markets decreased their price objective on American Tower from $255.00 to $245.00 and set an “outperform” rating for the company in a report on Wednesday, October 30th. Wells Fargo & Company downgraded American Tower from an “overweight” rating to an “equal weight” rating and cut their target price for the stock from $245.00 to $230.00 in a research report on Thursday, October 10th. Finally, JPMorgan Chase & Co. upped their target price on American Tower from $240.00 to $250.00 and gave the stock an “overweight” rating in a research report on Monday, September 23rd. Four investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $235.54.
American Tower Profile
American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities.
Further Reading
- Five stocks we like better than American Tower
- 3 Healthcare Dividend Stocks to Buy
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to buy stock: A step-by-step guide for beginners
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Why Are These Companies Considered Blue Chips?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for American Tower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Tower and related companies with MarketBeat.com's FREE daily email newsletter.